✦ LIBER ✦

Clinical symptoms according to genotype amongst patients with hereditary haemorrhagic telangiectasia

✍ Scribed by A. D. KJELDSEN; T. R. MØLLER; K. BRUSGAARD; P. VASE; P. E. ANDERSEN

Book ID: 108862112
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 94 KB
Volume: 258
Category: Article
ISSN: 0954-6820
DOI: 10.1111/j.1365-2796.2005.01555.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Complications and clinical outcome of he

Complications and clinical outcome of hepatic artery embolisation in patients with hereditary haemorrhagic telangiectasia

✍ Ajay Chavan, Lars Luthe, Michael Gebel, Hannelore Barg-Hock… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 252 KB

Specific cancer rates may differ in pati

Specific cancer rates may differ in patients with hereditary haemorrhagic telangiectasia compared to controls

✍ Hosman, Anna E; Devlin, Hannah L; Silva, B; Shovlin, Claire L 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 553 KB

Subcutaneous temporal abscess as a clini

Subcutaneous temporal abscess as a clinical manifestation of pulmonary arteriovenous malformations in a patient with hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease)

✍ S. Haarmann; A.S. Budihardja; F. Hölzle; K.D. Wolff 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 610 KB

Clinical usefulness of subgrouping of pa

Clinical usefulness of subgrouping of patients with non-cardiac chest pain according to characteristic symptoms in Korea

✍ Jeong Hwan Kim; Poong-Lyul Rhee; Eun-Ha Park; Hee Jung Son; Jae J Kim; Jong Chul 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Dose-Finding and Pharmacokinetic Study t

Dose-Finding and Pharmacokinetic Study to Optimize the Dosing of Irinotecan According to the UGT1A1 Genotype of Patients With Cancer

✍ Innocenti, F.; Schilsky, R. L.; Ramirez, J.; Janisch, L.; Undevia, S.; House, L. 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 141 KB